Axitinib in recurrent or metastatic nasopharyngeal carcinoma (NPC): final result of a phase 2 clinical trial with pharmacokinetic (PK) correlation
Journal article published in 2016 by
E. P. Hui,
B. B. Ma,
F. Mo,
M. K. Kam,
S. L. Chan 
,
H. H. Loong,
R. Ho,
S. F. Leung,
A. D. King,
K. Wang,
A. Ahuja,
C. M. Chan,
C. W. Hui,
C. H. Wong,
A. T. C. Chan
,
H. H. Loong,
R. Ho,
S. F. Leung,
A. D. King,
K. Wang,
A. Ahuja,
C. M. Chan,
C. W. Hui,
C. H. Wong,
A. T. C. Chan
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 